← Evidence library

BIB_390

🟢 Ni et al. 2026 Am J Epidemiol (MIA / University of Sydney) — absolute risk of 2nd primary cancer after 1st melanoma: 5-yr 2nd-primary-MELANOMA risk 7.6%; 23.7% develop ANY 2nd primary. Largest competing-risk-adjusted cohort (n=154,695). DIRECTLY refreshes TASK07 + the two new pigmented lesions on the 2026-05-26 agenda.

Evidence grade

A

Tier

1 (Am J Epidemiol, peer-reviewed; n=154,695 population cohort, Fine-

Cited by tasks

5, 7, 14, 23, 24

Identifiers

DOI:10.1093/aje/kwaf068 · PMID:40176284

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_390/findings.md (research corpus). This page is a short context summary — not individualised medical advice.